BackRhelion Life Sciences Overview

Rhelion Life Sciences Common Stock

Latest common stock for TRUFF: $51M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$51.40M
↑ 18.21% YoYΔ $7.92M vs prior year quarter

Peer trimmed avg / median

Loading

Rhelion Life Sciences Common Stock History

Loading

Rhelion Life Sciences vs. peers: Common Stock Comparison

Loading

Rhelion Life Sciences Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Rhelion Life Sciences (TRUFF) FAQ

As of the most recent data (June 2026), TRUFF shows a common stock of $51M. That compares with $43M in the prior-year period — up 18.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRUFF's common stock is now $51M (was $43M) — a 18.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Rhelion Life Sciences is outperforming or lagging.

Tracking TRUFF's common stock over time shows whether Rhelion Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $51M That compares with $43M in the prior-year period — up 18.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Rhelion Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $51M) with ownership activity and broader fundamentals.

Questions & Answers